Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Bando

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
International Journal of Clinical Oncology|July 22, 2021
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancerHiroya Taniguchi, Toshiki Masuishi, Akihito Kawazoe, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
International Journal of Clinical Oncology|November 21, 2025
Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resectionHajime Kamiya, Shin Kobayashi, Masashi Kudo, et al.
Cancer Science|September 8, 2011
Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cellsTadaaki Yamada, Hideaki Bando, Shinji Takeuchi, et al.
Cancer Science|July 16, 2020
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th editionHiromichi Ebi, Hideaki Bando, Hiroya Taniguchi, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy]Yusuke Yoda, Takayuki Yoshino, Shigenori Kadowaki, et al.
Cancer Science|February 27, 2016
Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumorsTakayuki Yoshino, Takashi Kojima, Hideaki Bando, et al.
BMC Cancer|February 2, 2018
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascitesHiroshi Matsumoto, Akihito Kawazoe, Kaoru Shimada, et al.
Clinical Colorectal Cancer|January 3, 2016
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single InstitutionDaisuke Kotani, Kohei Shitara, Akihito Kawazoe, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
International Journal of Clinical Oncology|July 22, 2021
Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancerHiroya Taniguchi, Toshiki Masuishi, Akihito Kawazoe, et al.
Nature Reviews. Clinical Oncology|April 9, 2015
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateNaoko Takebe, Lucio Miele, Pamela Jo Harris, et al.
International Journal of Clinical Oncology|November 21, 2025
Prognostic stratification of recurrent colorectal liver metastasis: impact of recurrence-free interval, tumor numbers, and size on repeat liver resectionHajime Kamiya, Shin Kobayashi, Masashi Kudo, et al.
Cancer Science|September 8, 2011
Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cellsTadaaki Yamada, Hideaki Bando, Shinji Takeuchi, et al.
Cancer Science|July 16, 2020
Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, 4th editionHiromichi Ebi, Hideaki Bando, Hiroya Taniguchi, et al.
BMC Cancer|November 16, 2016
Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trialsYoshiaki Nagatani, Kohei Shitara, Hideaki Bando, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2009
[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy]Yusuke Yoda, Takayuki Yoshino, Shigenori Kadowaki, et al.
Cancer Science|February 27, 2016
Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumorsTakayuki Yoshino, Takashi Kojima, Hideaki Bando, et al.
BMC Cancer|February 2, 2018
A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascitesHiroshi Matsumoto, Akihito Kawazoe, Kaoru Shimada, et al.
Clinical Colorectal Cancer|January 3, 2016
Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single InstitutionDaisuke Kotani, Kohei Shitara, Akihito Kawazoe, et al.
Pageof 19